Announcements Trials
Browse Landscape

Phase

Phase NA 3Phase 2/3 2Phase 2 2Phase 4 1

Status

Completed 44Terminated 19Recruiting 13Active not recruiting 9Withdrawn 5Not yet recruiting 3Unknown 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Plasma cell 1Other hematologic neoplasm 1

Conditions

Multiple Myeloma 1Hematologic Neoplasms 1

Interventions

Cisplatin 270Oxaliplatin 195Carboplatin 191Capecitabine 184Docetaxel 178apatinib 164Paclitaxel 163Bevacizumab 159Gemcitabine 156Radiotherapy 147camrelizumab 146Fluorouracil 144Cyclophosphamide 126Irinotecan 120Drug Therapy 119sintilimab 108Etoposide 99anlotinib 90S 1 (combination) 89Leucovorin 86pembrolizumab 85toripalimab 78Pemetrexed 78Doxorubicin 77tislelizumab 76Dexamethasone 71Trastuzumab 65Neoadjuvant Therapy 65Rituximab 62Cetuximab 62

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 2 × Unknown × Stem Cell Transplantation × Clear all
NCT01374841 2023-06-28

Hematopoietic Cell Transplantation for Patients With Hematologic Malignancies Using Related, HLA-Haploidentical Donors

European Institute of Oncology

Phase 2 Unknown
20 enrolled
Other hematologic neoplasm

Hematologic Neoplasms

NCT00327314 2006-12-28

Non-Myeloablative Allogeneic Transplantation From Unrelated Donors in Multiple Myeloma

Azienda Ospedaliera San Giovanni Battista

Phase 2 Unknown
100 enrolled
Plasma cell

Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡